PSS1: Effect of Pumpkin Seeds on the Dietary Fatty Acid Intake and Blood Pressure in Women

Sponsor
Texas Woman's University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01928966
Collaborator
(none)
0
1
2
15
0

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if the inclusion of 1.5 ounces of pumpkin seeds per day in the diet of women will alter dietary fatty acid intake or blood pressure.

Condition or Disease Intervention/Treatment Phase
  • Other: Pumpkin Seeds
N/A

Detailed Description

Cardiovascular disease is the number one cause of morbidity and mortality in United States. Diets high in polyunsaturated and monounsaturated fatty acids have been shown to decrease the risk of cardiovascular disease. Pumpkin seeds are a good source of monounsaturated and polyunsaturated fatty acids. Oil extracted from pumpkin seeds has been shown to lower blood pressure. One purpose of this study is to determine whether eating 1.5 ounces of pumpkin seeds per day will improve polyunsaturated and monounsaturated fatty acid intake in the diet in healthy adult women. Another purpose of this study is to determine whether eating 1.5 ounces of pumpkin seeds a day will lower blood pressure.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of Pumpkin Seeds on the Dietary Fatty Acid Intake and Blood Pressure in Women
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Nov 1, 2014
Actual Study Completion Date :
Nov 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group I - Pumpkin Seeds

First four weeks of study: consume perceived normal diet; Second four weeks of study: receive 1.5 ounces of pumpkin seeds per day for consumption; Third four weeks of the study: consume their perceived normal diet.

Other: Pumpkin Seeds
Participants will be asked to consume 1.5 ounces of raw, unsalted pumpkin seeds per day. The 1.5 ounces will be split in to two servings (each 0.75 ounces).

Active Comparator: Group II - Pumpkin Seeds

First four weeks of study: consume perceived normal diet; Second four week period: consume perceived normal diet; Third four week period: receive 1.5 ounces of pumpkin seeds per day for consumption.

Other: Pumpkin Seeds
Participants will be asked to consume 1.5 ounces of raw, unsalted pumpkin seeds per day. The 1.5 ounces will be split in to two servings (each 0.75 ounces).

Outcome Measures

Primary Outcome Measures

  1. Dietary fatty acid intake [12 weeks]

    The dietary fatty acid intake, specifically monounsaturated and polyunsaturated fatty acids, will be measured three times over the course of a twelve week period to determine if fatty acid intake changed during the intervention.

  2. Blood pressure [12 weeks]

    Blood pressure will be measured at every meeting to determine if the addition of pumpkin seeds to the diet altered blood pressure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Female

  • Over the age of 18

  • Able to read, write, and speak English

  • Able to keep a three-day diet diary

  • Willing and able to consume pumpkin seeds

Exclusion Criteria:
  • Pregnant or planning to become pregnant

  • Allergic to pumpkin seeds

  • High blood pressure

  • Regularly consuming pumpkin seeds (more than 4 times per month)

  • Taking blood pressure medication

  • Liver disease

  • Kidney disease

  • Gastrointestinal disease

  • History of bariatric surgery

  • History of a major cardiovascular event

  • Heart disease

  • Currently undergoing cancer treatment (except nonmelanoma cancer)

  • Following a weight control diet

  • Following a disease specific diet

  • Following a vegan diet

  • Have a diagnosed eating disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Texas Woman's University Houston Texas United States 77030

Sponsors and Collaborators

  • Texas Woman's University

Investigators

  • Study Chair: John D Radcliffe, PhD, Texas Woman's University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Texas Woman's University
ClinicalTrials.gov Identifier:
NCT01928966
Other Study ID Numbers:
  • TWU-1PS
First Posted:
Aug 27, 2013
Last Update Posted:
May 30, 2017
Last Verified:
May 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Texas Woman's University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 30, 2017